Tissue Repair Company
	Operator of biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. The company\'s scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development.
	['', 'tissue repair', ' ', 'tissue regeneration', ' ', 'gene therapy', '']
ConjuChem
	Developer of novel therapeutics with an initial focus on diabetes. The company makes use of its platforms namely drug affinity complex (DAC) and preformed conjugate drug affinity complex (PC-DAC) to develop new drugs, moreover the company is currently managing many research programs in-house and has one product in clinical development.
	['diabetes ', 'growth deficiencies', '']
Spark Therapeutics
	Developer of gene therapy products. The company develops gene therapy products to address debilitating diseases including retinal dystrophies.
	['', 'gene therapy', ' ', 'disease treatment', ' ', 'medical research', '']
REGENXBIO
	Operator of an adeno-associated virus gene therapy company. The company develops proprietary gene therapy tech to advance treatments for lysosomal storage disorders and ocular diseases, as well as other serious diseases.
	['', 'gene therapy', ' adeno-associated ', 'viral vector', ' ', 'clinical trail', '']
Plexpress
	Developer of novel gene expression analysis systems. The company is developing and marketing novel gene expression analysis assay called TRAC which helps to serve a range of applications and experimental systems, including ADME-Tox screening and disease research. Plexpress was established as a spinoff from the Finnish Technology Research Center (VTT) in 2007.
	['', 'analysis system', ' ', 'novel gene expression analysis', ' ', 'disease research', '']
Xenon Pharmaceuticals
	Developer of medicines focused on rare diseases. The company\'s core enabling discovery platform is focused on studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.
	['', 'rare disease', ' channelopathy ', 'gene therapy', ' ', 'discovery platform', ' ', 'ion channel mutation', '']
Somatix Therapy
	Developer of gene therapy. The company engages in research, development and commercialization of proprietary processes for the genetic modification of cells and their use in the treatment of human disease.
	['genetic ', 'gene therapy', '']
Dimension Therapeutics
	Developer of gene therapies for rare diseases. The company develops novel treatment and focus on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia and building out a world-class product engine for adeno-associated virus (AAV) therapeutics.
	['', 'novel treatment', ' ', 'gene therapy', ' ', 'clinical development', '']
